After grilling an NIH scientist over covid emails, Congress turns to Anthony Fauci

FHS
May 31, 2024
11:04 am

Former National Institutes of Health official Anthony Fauci has faced many hostile questions from members of Congress, but when he appears before a House panel on Monday, he’ll have something new to answer for: a trove of incendiary emails written by one of his closest advisers.

Lexicon resubmits type 1 diabetes drug to FDA five years after rejection

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 22, 2024

Relief Therapeutics Announces Executive Changes – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Personnel 03-Jun-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

June 4, 2024

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in

October 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.